Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
Identifieur interne : 000A20 ( Ncbi/Curation ); précédent : 000A19; suivant : 000A21Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
Auteurs : Birgit Högl [Autriche] ; Klaus Seppi ; Elisabeth Brandauer ; Susanne Glatzl ; Birgit Frauscher ; Ulrike Niedermüller ; Gregor Wenning ; Werner Poewe [Autriche]Source :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2003.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (therapeutic use), Case-Control Studies, Disorders of Excessive Somnolence (etiology), Disorders of Excessive Somnolence (psychology), Dopamine Agonists (therapeutic use), Female, Humans, Male, Parkinson Disease (complications), Parkinson Disease (drug therapy), Questionnaires, Severity of Illness Index, Sleep, Snoring.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- etiology : Disorders of Excessive Somnolence.
- psychology : Disorders of Excessive Somnolence.
- Aged, Case-Control Studies, Female, Humans, Male, Questionnaires, Severity of Illness Index, Sleep, Snoring.
Abstract
We evaluated the frequency and severity of excessive daytime sleepiness in an outpatient population with Parkinson's disease in comparison to age-matched controls and examined its relationship with antiparkinsonian drug therapy and sleep history. Increased daytime sleepiness and involuntary sleep episodes have been described in Parkinson's disease, but the etiology is not completely understood. The Epworth Sleepiness Scale (ESS), a validated questionnaire for daytime sleepiness, was prospectively administered to 99 consecutive outpatients with Parkinson's disease and 44 age-matched controls. In addition, a short sleep-screening questionnaire was used. The ESS revealed significantly increased daytime sleepiness in PD patients compared to controls (7.5 +/- 4.6 vs. 5.8 +/- 3.0, P = 0.013). The ESS score was abnormally high (10 or more) in 33 % of PD patients and 11.4% of controls (P = 0.001). ESS was not different between PD patients on levodopa monotherapy and those on levodopa and dopamine agonists, or between patients taking ergoline or non-ergoline dopamine agonists. In PD patients and in controls, sleepiness was significantly associated with reported heavy snoring. Increased daytime sleepiness is more frequent in patients with PD than in elderly controls. Similar to controls, increased daytime sleepiness in PD patients is correlated with heavy snoring.
DOI: 10.1002/mds.10365
PubMed: 12621636
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003831
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003831
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003755
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000A20
Links to Exploration step
pubmed:12621636Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.</title><author><name sortKey="Hogl, Birgit" sort="Hogl, Birgit" uniqKey="Hogl B" first="Birgit" last="Högl">Birgit Högl</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck</wicri:regionArea><wicri:noRegion>A-6020 Innsbruck</wicri:noRegion></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name></author><author><name sortKey="Brandauer, Elisabeth" sort="Brandauer, Elisabeth" uniqKey="Brandauer E" first="Elisabeth" last="Brandauer">Elisabeth Brandauer</name></author><author><name sortKey="Glatzl, Susanne" sort="Glatzl, Susanne" uniqKey="Glatzl S" first="Susanne" last="Glatzl">Susanne Glatzl</name></author><author><name sortKey="Frauscher, Birgit" sort="Frauscher, Birgit" uniqKey="Frauscher B" first="Birgit" last="Frauscher">Birgit Frauscher</name></author><author><name sortKey="Niedermuller, Ulrike" sort="Niedermuller, Ulrike" uniqKey="Niedermuller U" first="Ulrike" last="Niedermüller">Ulrike Niedermüller</name></author><author><name sortKey="Wenning, Gregor" sort="Wenning, Gregor" uniqKey="Wenning G" first="Gregor" last="Wenning">Gregor Wenning</name></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><country>Autriche</country><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12621636</idno><idno type="pmid">12621636</idno><idno type="doi">10.1002/mds.10365</idno><idno type="wicri:Area/PubMed/Corpus">003831</idno><idno type="wicri:Area/PubMed/Curation">003831</idno><idno type="wicri:Area/PubMed/Checkpoint">003755</idno><idno type="wicri:Area/Ncbi/Merge">000A20</idno><idno type="wicri:Area/Ncbi/Curation">000A20</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.</title><author><name sortKey="Hogl, Birgit" sort="Hogl, Birgit" uniqKey="Hogl B" first="Birgit" last="Högl">Birgit Högl</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.</nlm:affiliation><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck</wicri:regionArea><wicri:noRegion>A-6020 Innsbruck</wicri:noRegion></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name></author><author><name sortKey="Brandauer, Elisabeth" sort="Brandauer, Elisabeth" uniqKey="Brandauer E" first="Elisabeth" last="Brandauer">Elisabeth Brandauer</name></author><author><name sortKey="Glatzl, Susanne" sort="Glatzl, Susanne" uniqKey="Glatzl S" first="Susanne" last="Glatzl">Susanne Glatzl</name></author><author><name sortKey="Frauscher, Birgit" sort="Frauscher, Birgit" uniqKey="Frauscher B" first="Birgit" last="Frauscher">Birgit Frauscher</name></author><author><name sortKey="Niedermuller, Ulrike" sort="Niedermuller, Ulrike" uniqKey="Niedermuller U" first="Ulrike" last="Niedermüller">Ulrike Niedermüller</name></author><author><name sortKey="Wenning, Gregor" sort="Wenning, Gregor" uniqKey="Wenning G" first="Gregor" last="Wenning">Gregor Wenning</name></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><country>Autriche</country><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="ISSN">0885-3185</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>Case-Control Studies</term><term>Disorders of Excessive Somnolence (etiology)</term><term>Disorders of Excessive Somnolence (psychology)</term><term>Dopamine Agonists (therapeutic use)</term><term>Female</term><term>Humans</term><term>Male</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Sleep</term><term>Snoring</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Disorders of Excessive Somnolence</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Disorders of Excessive Somnolence</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Sleep</term><term>Snoring</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We evaluated the frequency and severity of excessive daytime sleepiness in an outpatient population with Parkinson's disease in comparison to age-matched controls and examined its relationship with antiparkinsonian drug therapy and sleep history. Increased daytime sleepiness and involuntary sleep episodes have been described in Parkinson's disease, but the etiology is not completely understood. The Epworth Sleepiness Scale (ESS), a validated questionnaire for daytime sleepiness, was prospectively administered to 99 consecutive outpatients with Parkinson's disease and 44 age-matched controls. In addition, a short sleep-screening questionnaire was used. The ESS revealed significantly increased daytime sleepiness in PD patients compared to controls (7.5 +/- 4.6 vs. 5.8 +/- 3.0, P = 0.013). The ESS score was abnormally high (10 or more) in 33 % of PD patients and 11.4% of controls (P = 0.001). ESS was not different between PD patients on levodopa monotherapy and those on levodopa and dopamine agonists, or between patients taking ergoline or non-ergoline dopamine agonists. In PD patients and in controls, sleepiness was significantly associated with reported heavy snoring. Increased daytime sleepiness is more frequent in patients with PD than in elderly controls. Similar to controls, increased daytime sleepiness in PD patients is correlated with heavy snoring.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A20 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000A20 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:12621636
|texte= Increased daytime sleepiness in Parkinson's disease: a questionnaire survey.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:12621636" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |